Registration now open for the 9th IOF Asia-Pacific Bone Health Conference in Tokyo
Meeting Announcement
Chuo University ELSI Center and The University of Osaka established the Research Center on Ethical, Legal and Social Issues (The University of Osaka ELSI Center) jointly hosted the "University ELSI Summit", a two-day event held on March 15th and 16th, 2025 (Saturday-Sunday) at Chuo University's Korakuen Campus (Bunkyo-ku, Tokyo, Japan).
ELSI (Ethical, Legal and Social Issues) and RRI (Responsible Research and Innovation) are seeing rapid development globally. These approaches are being examined across various fields both domestically and internationally. The ELSI University Summit focused on ELSI and RRI initiatives in academia and industry. These initiatives concentrate on research areas related to advanced AI and social challenges. The summit included reports from multiple stakeholders responsible for development, utilization, and regulation — including the business community, government agencies, educational institutions, science and engineering researchers, and humanities researchers. In addition, through Q&A sessions and panel discussions, the summit engaged in intensive discussions about their respective roles and the importance of collaboration. The event attracted a total of 607 on-site participants and online ones.
BGI Genomics has successfully wrapped up its inaugural Whole Exome Sequencing (WES) Interpretation of Genetic Diseases Training Workshop for Southeast Asia, marking a significant milestone in international genomics education.
Held at the BGI Center in late May, the workshop brought together emerging healthcare professionals and researchers from Thailand, Indonesia, and Vietnam for a week of intensive, hands-on learning.
The American Society of Echocardiography (ASE) and Cardiovascular Research Foundation® (CRF®) are pleased to announce a new educational collaboration to foster shared learning, drive innovation, and strengthen connections across the cardiovascular community.
1 in 3 cancer patients may experience serious cardiovascular side effects from treatment. The European Society of Cardiology (ESC), through its Council of Cardio-Oncology is launching a dedicated conference to focus on the growing epidemic. Taking place on 20 and 21 June in Florence, Italy, the conference will emphasise multidisciplinary collaboration. Highlights include joint sessions with related organisations, as well as interactive workshops, and case-based sessions.